These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 36912585)

  • 1. Update on the treatment of chronic pulmonary aspergillosis.
    Armstrong-James D; Kosmidis C; Bromley M
    Curr Opin Infect Dis; 2023 Apr; 36(2):146-151. PubMed ID: 36912585
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antifungal Therapies for Aspergillus spp.: Present and Future.
    Eschenauer GA
    Semin Respir Crit Care Med; 2024 Feb; 45(1):61-68. PubMed ID: 38151025
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Echinocandins: a wealth of choice--how clinically different are they?
    Zaas AK
    Curr Opin Infect Dis; 2008 Aug; 21(4):426-32. PubMed ID: 18594297
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pulmonary aspergillosis: recent advances.
    Thompson GR; Patterson TF
    Semin Respir Crit Care Med; 2011 Dec; 32(6):673-81. PubMed ID: 22167395
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An overview of the available treatments for chronic cavitary pulmonary aspergillosis.
    Sehgal IS; Dhooria S; Muthu V; Prasad KT; Agarwal R
    Expert Rev Respir Med; 2020 Jul; 14(7):715-727. PubMed ID: 32249630
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intravenous therapy for chronic pulmonary aspergillosis: A systematic review and meta-analysis.
    Bongomin F; Asio LG; Olum R; Denning DW
    Mycoses; 2020 Sep; 63(9):921-927. PubMed ID: 32542771
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacological management of antifungal agents in pulmonary aspergillosis: an updated review.
    Echeverria-Esnal D; Martín-Ontiyuelo C; Navarrete-Rouco ME; Barcelo-Vidal J; Conde-Estévez D; Carballo N; De-Antonio Cuscó M; Ferrández O; Horcajada JP; Grau S
    Expert Rev Anti Infect Ther; 2022 Feb; 20(2):179-197. PubMed ID: 34328373
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prophylaxis and treatment of invasive aspergillosis with voriconazole, posaconazole and caspofungin: review of the literature.
    Karthaus M
    Eur J Med Res; 2011 Apr; 16(4):145-52. PubMed ID: 21486728
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New pharmacological opportunities for the treatment of invasive mould diseases.
    Ledoux MP; Toussaint E; Denis J; Herbrecht R
    J Antimicrob Chemother; 2017 Mar; 72(suppl_1):i48-i58. PubMed ID: 28355467
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optimized Antifungal Therapy for Chronic Pulmonary Aspergillosis.
    Yagi Y; Yamagishi Y; Hamada Y
    Med Mycol J; 2024; 65(3):59-65. PubMed ID: 39218648
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cyclical caspofungin for chronic pulmonary aspergillosis in sarcoidosis.
    Keir GJ; Garfield B; Hansell DM; Loebinger MR; Wilson R; Renzoni EA; Wells AU; Maher TM
    Thorax; 2014 Mar; 69(3):287-8. PubMed ID: 24029745
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Addressing the "Hot Spots" in the management of invasive aspergillosis].
    Kontoyiannis D
    Med Mal Infect; 2007; 37 Suppl 2():9-11. PubMed ID: 17933659
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evolution of antifungals for invasive mold infections in immunocompromised hosts, then and now.
    Weiss ZF; Little J; Hammond S
    Expert Rev Anti Infect Ther; 2023 May; 21(5):535-549. PubMed ID: 37104686
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antifungal management.
    Wingard J
    Biol Blood Marrow Transplant; 2010 Mar; 16(3):441-2. PubMed ID: 20152732
    [No Abstract]   [Full Text] [Related]  

  • 15. A prospective, multicenter study of caspofungin for the treatment of documented Candida or Aspergillus infections in pediatric patients.
    Zaoutis TE; Jafri HS; Huang LM; Locatelli F; Barzilai A; Ebell W; Steinbach WJ; Bradley J; Lieberman JM; Hsiao CC; Seibel N; Laws HJ; Gamba M; Petrecz M; Taylor AF; Strohmaier KM; Chow JW; Kartsonis NA; Ngai AL
    Pediatrics; 2009 Mar; 123(3):877-84. PubMed ID: 19255017
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Breakthrough pulmonary Aspergillus fumigatus infection with multiple triazole resistance in a Spanish patient with chronic myeloid leukemia.
    Mellado E; De La Camara R; Buendía B; Rodriguez-Tudela JL; Cuenca-Estrella M
    Rev Iberoam Micol; 2013 Jan; 30(1):64-8. PubMed ID: 22986228
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antifungal therapy for invasive fungal diseases in allogeneic stem cell transplant recipients: an update.
    Wilson DT; Drew RH; Perfect JR
    Mycopathologia; 2009 Dec; 168(6):313-27. PubMed ID: 19308672
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Combination therapy for invasive aspergillosis].
    Ruiz-Camps I
    Enferm Infecc Microbiol Clin; 2011 Mar; 29 Suppl 2():38-42. PubMed ID: 21420576
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combination antifungal therapy for invasive aspergillosis: utilizing new targeting strategies.
    Steinbach WJ
    Curr Drug Targets Infect Disord; 2005 Sep; 5(3):203-10. PubMed ID: 16181140
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Caspofungin: a review of its use in oesophageal candidiasis, invasive candidiasis and invasive aspergillosis.
    Keating G; Figgitt D
    Drugs; 2003; 63(20):2235-63. PubMed ID: 14498760
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.